Pyruvate dehydrogenase complex—enzyme 2, a new target for Listeria spp. detection identified using combined phage display technologies
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsMoreira, Gustavo Marçal Schmidt Garcia
Köllner, Sarah Mara Stella
Moreira, Ângela Nunes
Conceição, Fabricio Rochedo
MetadataShow full item record
AbstractThe genus Listeria comprises ubiquitous bacteria, commonly present in foods and food production facilities. In this study, three different phage display technologies were employed to discover targets, and to generate and characterize novel antibodies against Listeria: antibody display for biomarker discovery and antibody generation; ORFeome display for target identification; and single-gene display for epitope characterization. With this approach, pyruvate dehydrogenase complex-enzyme 2 (PDC-E2) was defined as a new detection target for Listeria, as confirmed by immunomagnetic separation-mass spectrometry (IMS-MS). Immunoblot and fluorescence microscopy showed that this protein is accessible on the bacterial cell surface of living cells. Recombinant PDC-E2 was produced in E. coli and used to generate 16 additional antibodies. The resulting set of 20 monoclonal scFv-Fc was tested in indirect ELISA against 17 Listeria and 16 non-Listeria species. Two of them provided 100% sensitivity (CI 82.35-100.0%) and specificity (CI 78.20-100.0%), confirming PDC-E2 as a suitable target for the detection of Listeria. The binding region of 18 of these antibodies was analyzed, revealing that ≈ 90% (16/18) bind to the lipoyl domains (LD) of the target. The novel target PDC-E2 and highly specific antibodies against it offer new opportunities to improve the detection of Listeria.
CitationSci Rep. 2020 Sep 17;10(1):15267. doi: 10.1038/s41598-020-72159-4.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
PublisherSpringer Science and Business Media LLC
SponsorsConselho Nacional de Desenvolvimento Científico e Tecnológico
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Isolation of phage-display library-derived scFv antibody specific to Listeria monocytogenes by a novel immobilized method.
- Authors: Nguyen XH, Trinh TL, Vu TB, Le QH, To KA
- Issue date: 2018 Feb
- Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2).
- Authors: Cha S, Leung PS, Van de Water J, Tsuneyama K, Joplin RE, Ansari AA, Nakanuma Y, Schatz PJ, Cwirla S, Fabris LE, Neuberger JM, Gershwin ME, Coppel RL
- Issue date: 1996 Oct 1
- Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.
- Authors: Rowley MJ, Scealy M, Whisstock JC, Jois JA, Wijeyewickrema LC, Mackay IR
- Issue date: 2000 Mar 15
- Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.
- Authors: Potter KN, Thomson RK, Hamblin A, Richards SD, Lindsay JG, Stevenson FK
- Issue date: 2001 Feb 9
- Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology.
- Authors: Sompunga P, Pruksametanan N, Rangnoi K, Choowongkomon K, Yamabhai M
- Issue date: 2019 Aug 15